Premium
Hong Kong-based alternative investment firm PAG Asia Capital has joined two Indian private equity firms to build a bulk-drugs...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
